Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Wake me up when we see volume 1 mill plus in a day

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Feb 10, 2022 8:01pm

143 Views

Post# 34418721

RE:RE:RE:Wake me up when we see volume 1 mill plus in a day

Howard gets an A IF he delivers by end of February.

He gets a B if before March, a C if before April and a D before end of May. If nothing before beginning of June he gets an F.

If he drives the price above 80 cents then add a plus on to each.

April 9, 2019 - 47k traded
April 10, 2019 - 9 MILLION shares traded

That my furry loving friend is how this puppy rolls.

<< Previous

Bullboard Posts

Next >>

Boeing workers end strike, return to work